Handoo S, Arora V, Khera D, Nandi P, Sahu KS. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int J Pharm Investig 2012; 2(3): 99-105.
Wu Y, Freed A, Lavrich D, et al. Strategies of bringing drug product marketing applications to meet current regulatory standards. AAPS PharmSciTech 2015; 4(16): 986-91.
Lon CT, Tsuyuoka R, Phanouvong S, et al. Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg 2006; 100(11): 1019-24.
Latt NN, Cho MS, Htun MMN, et al. Healthcare in Myanmar. Nagoya J Med Sci 2016; 78(2): 123-34.
Badjatya KJ, Bodla R, Musyuni P. Export registration of pharmaceuticals in Rest Of World countries (ROW). J Drug Deliv Ther 2013; 3(1): 61-4.
Pateriya S, Janodia MD, Deshpande PB, et al. Regulatory aspects of pharmaceuticals’ exports in Gulf Cooperation Council Countries. J Young Pharm 2011; 3(2): 155-62.
Pezzola A, Sweet C. Global pharmaceutical regulation: The challenge of integration for developing states. Global Health 2016; 12(1): 1-18.
Badjatya KJ. Overview of drug registration requirements for pharmaceuticals in emerging market. J Drug Deliv Ther 2013; 3(2): 227-32.
Hashan H, Aljuffali I, Patel P, Walker S. The Saudi Arabia food and drug authority: An evaluation of the registration process and good review practices in Saudi Arabia in comparison with Australia, Canada and Singapore. Pharmaceut Med 2016; 30: 37-47.
Sravani M, Gowthami B, Prabhahar E, Rao RN. Regulatory aspects of pharmaceuticals in Gulf Co-operation Council Countries. Int J Pharm Chem Res 2017; 3(3): 397-414.
Suthakaran R. Comparative study of regulatory requirements for the approval of generic drugs for Association of South East Asian Nation (ASEAN), Gulf Co-Operative Council (GCC) & United States Food and Drug Administration (USFDA). J Pharm Res 2014; 8(1): 59-63.